AF700-conjugated CD274 (PD-L1) Antibody (29E.2A3)

(Synonyms: CD274 (PD-L1),CD274-AF700,29E.2A3)

AF700-conjugated CD274 (PD-L1) Antibody (29E.2A3) is a Mouse-derived and AF700 conjugated monoclonal antibody, targeting to CD274 (PD-L1).

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    Mouse IgG2b,κ

  • Application:

    FC

  • Reactivity :

    Human

  • Formulation:

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Conjugation:
    AF700

Applications

Application
FC Info
FC: Flow Cytometry
Dilution Ratio 5 ul per 106 cells in a 100 µl suspension

Product Details

Description

AF700-conjugated CD274 (PD-L1) Antibody (29E.2A3) is a Mouse-derived and AF700 conjugated monoclonal antibody, targeting to CD274 (PD-L1).

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
Conjugation

AF700

Modification

Unmodified

Isotype

Mouse IgG2b,κ

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Storage & Stability

    Stored at 2-8°C for 1 year, protect from light, do not freeze.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    CD274 (PD-L1) is an important immune checkpoint ligand protein belonging to the B7 family of immunoregulatory molecules. By binding to PD-1 on the surface of T cells, PD-L1 inhibits T-cell activation and immune responses; it is a key mechanism of tumor immune escape and a major target for current immune checkpoint therapies.

  • Subcellular Localization

    Cell membrane; Single-pass type I membrane protein; Early endosome membrane; Single-pass type I membrane protein; Recycling endosome membrane; Single-pass type I membrane protein; Nucleus; Cell membrane; Single-pass type I membrane protein; Endomembrane system; Single-pass type I membrane protein; Secreted

  • Expression


    Tissue_specificity:It is highly expressed in the heart, skeletal muscle, placenta, and lungs. It is weakly expressed in the thymus, spleen, kidneys, and liver. It is expressed on activated T cells and B cells, dendritic cells, keratinocytes, and monocytes; it is widely expressed, with the highest expression in the lungs, liver, pituitary gland, and various peripheral blood cells (including neutrophils and certain subtypes of lymphocytes and myeloid cells) .

    Induction:Up-regulated on T- and B-cells, dendritic cells, keratinocytes and monocytes after LPS and IFNG activation. Up-regulated in B-cells activated by surface Ig cross-linking

  • Isoforms & Post-Translational Modification

    CD274 (PD-L1) has 4 isomers: Q9NZQ7-1: 33275 Da (predicted); Q9NZQ7-2: 20246 Da (predicted); Q9NZQ7-3: 20454 Da (predicted); Q9NZQ7-4: 28050 Da (predicted).
    Ubiquitinated; STUB1 likely mediates polyubiquitination of PD-L1/CD274 triggering its degradation. Ubiquitinated by MARCHF8; leading to degradation. Deubiquitinated by USP22; leading to stabilization

  • Subunit

    Interacts with PDCD1. Interacts (via transmembrane domain) with CMTM4 and CMTM6. Interacts with (phosphorylated) STAT3; promoting nuclear translocation. Interacts with CD80

  • Synonyms

    CD274 (PD-L1),CD274-AF700,29E.2A3

AF700-conjugated CD274 (PD-L1) Antibody (29E.2A3) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00